Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 145   

Articles published

VRX 233.48 -2.39 (-1.01%)
price chart
Is Valeant Pharmaceuticals Intl Inc. a Buy on Recent Acquisition News?
It never seems to end for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). The Wall Street Journal reported yesterday that Valeant would be acquiring Sprout Pharmaceuticals Inc., the maker of the controversial “female Viagra,” Addyi.
Valeant Pharmaceuticals International Inc. to buy 'female Viagra' ...  Financial Post
Valeant nears deal for 'female Viagra' maker Sprout Pharmaceuticals: WSJ  Business Insider
Valeant Pharmaceuticals International Inc topples RBC to emerge as Canada's ...
MONTREAL - Valeant Pharmaceuticals International Inc. has surpassed Royal Bank of Canada as the country's largest company by market value after shares shot up in the wake of solid second quarter results.
Buy Valeant Pharmaceuticals Intl Inc. for Global Pharmaceutical Diversification  The Motley Fool Canada
Valeant Pharmaceuticals Reports Second Quarter 2015 Financial Results  PR Newswire (press release)
Valeant Pharmaceuticals International Inc. is now worth more than Toronto ...
Valeant is in talks to acquire Amoun Pharmaceutical Co., one of the largest drugmakers in Egypt, according to people with knowledge of the matter, Bloomberg reported May 20.
Valeant now worth more than TD Bank as drugmakers surge  bnn.ca
Valeant challenges TD Bank to become Canada's second-largest stock  The Globe and Mail
Buy Valeant Pharmaceuticals Intl Inc. Now, or You'll Regret it Later
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), one of the largest specialty pharmaceutical companies in the world, announced better-than-expected second-quarter earnings results before the market opened on July 23, and its stock responded by ...
Morgan Stanley Lifts Target On Valeant From $235 To $284  Benzinga
Valeant Pharmaceuticals International Inc expands in Middle East with $800 ...
Valeant Pharmaceuticals International, Inc. said it will buy a major Egyptian pharmaceutical company for about US$800 million as a platform for further expansion in the Middle East and North Africa.
Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical  PR Newswire (press release)
Valeant Pharmaceuticals International Inc in advanced talks to buy Amoun ...
Valeant Pharmaceuticals International Inc. is in advanced negotiations to acquire Egyptian drugmaker Amoun Pharmaceutical Co.
Could the CEO of Valeant Pharmaceuticals Intl Inc. Be the Next Warren Buffett?  The Motley Fool Canada
Valeant Pharmaceuticals International, Inc. (VRX) Files Form 4 Insider ...  Insider Trading Report
Valeant Pharmaceuticals International Inc CEO primed for more deals
Michael Pearson's penchant for acquisitions has helped catapult Valeant Pharmaceuticals International Inc. to the heavyweight ranks of the TSX Composite Index, and the company's chief executive officer shows no signs of slowing down the deal flow.
Billionaire John Paulson Doubles Down on Valeant Pharmaceuticals Intl Inc.  The Motley Fool Canada
Valeant Pharmaceuticals Announces 2015 Annual Meeting Results  PR Newswire (press release)
Valeant Pharmaceuticals International Inc's biggest deal yet seen as a bet on ...
Canadian PressChief Executive Officer Mike Pearson said Valeant Pharmaceuticals International Inc is still focused on small- to medium-sized acquisitions, and may consider a larger deal if one presents itself.
Should You Buy Valeant Pharmaceuticals Intl Inc. on the Salix ...  The Motley Fool Canada
Why Aetna Inc (AET), Valeant Pharmaceuticals Intl Inc (VRX) and Tower ...  Investorplace.com
Valeant Pharmaceuticals International Inc's bid for Salix Pharmaceuticals ...
Canadian Press//Ryan RemiorzValeant Pharmaceuticals International Inc's chief executive Mike Pearson agreed to buy bowel drug maker Salix Pharmaceuticals Ltd in late February for about US$10 billion, or US$158 all cash offer per share.
Valeant Comments On Endo Offer To Acquire Salix  PR Newswire (press release)
Endo looks to crash $14.5bn Valeant-Salix deal  Financial Times
Valeant Pharmaceuticals International Inc. is becoming the 800-pound gorilla ...
Scott Eells/Bloomberg Valeant Pharmaceuticals International Inc. chief executive Michael Pearson, has stated his company's goal is to become one of the top five largest drugmakers in the world by 2016, which means reaching a market value of at least ...
Investing Like Ackman Lifts Canada Index as Valeant Gains  Bloomberg